News Picture Generic

The lab of the future is now

September 15, 2021

Chemical and Engineering News

Recent demonstrations of AI-directed automation may herald a new world for drug and materials discovery.

After making gradual inroads in drug and materials discovery in recent years, artificial intelligence is suddenly appearing in a new light. Autonomous labs that link AI-based data analysis to robotic synthesis and validation are being demonstrated in both academia and industry. These labs prefigure a new work environment in which machines perform many of the traditional functions of researchers. Proponents argue that this self-driven R&D environment will enhance the efforts of multidisciplinary scientists, who will maintain ultimate control. Chemical and drug firms are taking a serious look at what may be the lab of the future.

Read this inspiring arcticle:

The lab of the future is now

For more information about Chemspeed solutions:

FLEX ISYNTH for small-scale synthesis

FLEX ISYNTH for library synthesis

ISYNTH

For details please contact [email protected]

 

Other Recent News

Discover more news articles you might be interested in

Read more about Identifying critical powder properties for high-throughput dispensing of alumina and organic templates
News Picture 1 1 V2
Jun
16

Identifying critical powder properties for high-throughput dispensing of alumina and organic templates

Screening powder properties such as flowability, compressibility, and particle geometry is crucial for controlling ceramic processing, particularly in automated workflows that demand high reproducibility. Sacrificial templating for porous ceramics is well suited to automation because it is prone to variability arising from manual handling.

Read more about Integration of Machine Learning and Automated Synthesis for Accelerated Drug and Material Research
News Picture 1 1 V2
Jun
2

Integration of Machine Learning and Automated Synthesis for Accelerated Drug and Material Research

The challenges posed by global climate change and disease risks have intensified the demand for efficient and practical materials and molecules. Traditional trial-and-error approaches are becoming increasingly inefficient and resource-intensive. The rapid advancement of artificial intelligence (AI) has opened new avenues to accelerate research and shorten development cycles.

© Chemspeed Technologies 2026